Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Lymphoid × oblimersen × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Intraocular Lymphoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

ibrutinib 4 Rituximab 4 fludarabine phosphate 3 fludarabine 3 Bendamustine Hydrochloride 3 blinatumomab 2 Melphalan 2 Lenalidomide 2 Busulfan 2 Alemtuzumab 2 thymoglobulin 1 pirtobrutinib 1 ofatumumab 1 obinutuzumab 1 lirilumab 1 copanlisib 1 RFT5-SMPT-dgA immunotoxin 1 Leukapheresis 1 Immunotherapy, Adoptive 1 Everolimus 1 Cyclophosphamide 1 CT-P10 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡